By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors 3/2/2015 7:54:08 AM
National Cancer Institute Release: Raising Awareness About Cancer Clinical Trials In Multicultural Communities 2/19/2015 9:15:40 AM
UT Southwestern Medical Center Receives Key National Cancer Institute Funding To Plan First U.S. Center For Heavy Ion Radiation Therapy Research 2/11/2015 11:10:25 AM
Genalyte Inc. Completes First Phase Of National Cancer Institute Grant Program 1/28/2015 10:09:26 AM
Lion Biotechnologies, Inc. Amends CRADA With National Cancer Institute To Develop TIL Therapy For Additional Cancer Indications 1/26/2015 7:44:01 AM
MedImmune (AZN) Establishes Three-Year Partnership With National Cancer Institute To Advance Oncology Research 1/21/2015 9:32:53 AM
The Pancreatic Cancer Action Network And The National Cancer Institute's Frederick National Laboratory For Cancer Research Join Forces For Research Initiative 1/12/2015 8:59:13 AM
Corvida Medical Launches Research Study With Funding And Support From The National Cancer Institute 12/5/2014 11:16:21 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
12345678910...
//-->